Home › Funds › Mayar Capital Ltd. › JNJ

Mayar Capital Ltd. position in JNJ

JOHNSON & JOHNSON · Health Care

Mayar Capital Ltd. reported holding 1,641 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$434K, representing 0.55% of its reported portfolio and ranking #13 among its reported holdings. Mayar Capital Ltd. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.64K sh
Reported value held$434.44K
Portfolio Weight0.55%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Mayar Capital Ltd.'s JNJ position evolved

Mayar Capital Ltd. first disclosed a stake in JNJ in Q3 2023 at 35,199 shares (US$5.5M). The position peaked in Q3 2025 at 65,141 shares, worth US$12.1M. Across 13 filings, Mayar Capital Ltd. increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 1,641 shares valued at US$434K. Notable position changes include a 94% increase in Q4 2023 (shares rose 1% over the following quarter), a 52% trim in Q4 2025 (shares rose 18% over the following quarter), a 95% trim in Q1 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 35.20K $5.48M New
Q4 2023 68.43K $10.73M Add
Q1 2024 68.30K $10.80M Hold
Q2 2024 74.69K $10.92M Add
Q3 2024 71.49K $11.59M Reduce
Q4 2024 63.34K $9.16M Reduce
Q1 2025 64.94K $10.77M Add
Q2 2025 65.14K $9.95M Hold
Q3 2025 65.14K $12.08M Hold
Q4 2025 31.24K $6.47M Reduce
Q1 2026 1.64K $401.13K Reduce
Q2 2026 1.64K $416.76K Hold
Q3 2026 1.64K $434.44K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Mayar Capital Ltd. held JNJ?

Mayar Capital Ltd. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Mayar Capital Ltd.'s current position in JNJ?

As of Q3 2026, Mayar Capital Ltd. holds 1.64K shares of JNJ (JOHNSON & JOHNSON), valued at $434.44K, representing 0.55% of its reported portfolio and ranking #13.

Has Mayar Capital Ltd. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Mayar Capital Ltd. held unchanged its position in JNJ. The position peaked in Q3 2025 at 65.14K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.